Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the America
- Corax Consultants LLC
- 6. Apr. 2024
- 1 Min. Lesezeit
– Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024
Kommentare